Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications
ABSTRACT Background Today, treating cancer patients with monoclonal antibodies (mAbs), by targeting immune checkpoints, is one of the most outstanding immunotherapeutic methods. Immune checkpoints are special molecules having regulatory role in immune system responses. Once these molecules are prese...
Saved in:
| Main Authors: | Erfan Rezazadeh‐Gavgani, Reza Majidazar, Parisa Lotfinejad, Tohid Kazemi, Ali Shamekh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.70196 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Applications and challenges of immunotherapy in the management of gastric adenocarcinoma: current status and future perspectives
by: Zhiyao Chen, et al.
Published: (2025-03-01) -
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers
by: Ecem Kalemoglu, et al.
Published: (2025-04-01) -
Optimizing Immunotherapy: The Synergy of Immune Checkpoint Inhibitors with Artificial Intelligence in Melanoma Treatment
by: Mohammad Saleem, et al.
Published: (2025-04-01) -
Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade
by: Yan Zhang, et al.
Published: (2019-08-01) -
Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis
by: Antonious Hazim, et al.
Published: (2025-05-01)